And, that's fair. Watching the share price fall from $45 per share to around $8 has been a series of George Foremanesque gut punches….especially since the company has only reported encouraging data and updates since the merger. So, why the drop in sp? Well, the whole biotech sector has been slammed since February which was when IBRX made it's high. It's tough for an individual stock to do well when it's sector is getting murdered A Seeking Alpha analyst who remains bullish on IBRX also offered the following reason for the stock's decline. "Sorrento Therapeutics (SRNE) was expected to have 10 million shares of the combined company (IBRX) at the time of the merger. Sorrento and ImmunityBio founder, Dr. Patrick Soon-Shiong, are in a legal battle over a partnership that went sour. Perhaps, Sorrento has/is/going to unload that position considering they are trying to sue the company’s founder and major stakeholder. I want to stress that I don’t know if this has or will occur, but it isn’t out of the realm of possibility considering the current relationship and circumstances between the two parties." This makes sense to me. It also makes sense that IBRX should rebound after SRNE has finished dumping the 10 million shares. I still believe IBRX will move past the $45 mark it hit in February and am holding 27,800 shares @ $9.77.